Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Vertex Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Vertex Pharmaceuticals exhibits at Booth 1639 at ASH 2026 in New Orleans, and takes part in 2 sessions. Vertex Pharmaceuticals brings approved treatments for sickle cell disease and beta thalassemia, alongside medicines for cystic fibrosis and acute pain.

OrganizationASH 2026 Attendance
Large pharma
Biotechnology company whose approved medicines treat sickle cell disease, beta thalassemia, cystic fibrosis and acute pain, with a broad clinical pipeline.
Booth
Exhibiting at Booth 1639
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Vertex Pharmaceuticals

Tell us what you sell and we’ll find the people at Vertex Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction